New Headquarters: the opening ceremony

The 18th of July is in the history of Technogenetics and marks the beginning of new challenges for all of us.

With the great satisfaction and determination on the sidelines of the opening ceremony of Technogenetics’ New Headquarters, which hold on Tuesday 18 July 2017 in Lodi, Italy.

 

In the presence of numerous authorities, law enforcement agencies, trade partners and a Chinese delegation, the opening ceremony was dedicate to the new premises for research and production center of Technogenetics, an Italian excellence in the field of laboratory diagnostics and molecular genetics.

The realization of the new headquarters is among the first results of the huge investments that KHB has planned and is running in Italy. Thanks to an operation signed on 21 December 2015, Technogenetics has become a part of the giant Chinese group KHB and through a Joint Venture with KHB is preparing to contribute to medical and scientific progress on a global scale.

The inauguration of July 18, therefore, is a fundament for Technogenetics that will be.

New Technogenetics is a launch pad for our research and is the starting point for the creation of an International Group in Diagnostics that will be able to compete with the big players of the industry” S.Cincotti, CEO Technogenetics.

cincotti

"From now on, it doesn't change only the dress but all the organizational system. In 18 months, KHB, the financial and industrial partner, has already invested 10 of the 40 million of Euros planned for next 3-4 years. We have thus expanded and built new machinery for the R&D and production center of Lodi, where today there are 55 people working, some of whom were been employed in the past six months. Investments will be the driving force for growth not only in Italy but also in the world. The choice of Technogenetics by one of the leading Chinese players in the IVD industry confirms the Italian ability to attract investments thanks to technology and R&D; Technologies and R&D that cover all of Italy, with regard to Technogenetics, which boasts another R&D center in the South Italy where more than 10 researchers are employed. KHB's investment improves and even helps to grow an Italian company, already a leader in Italy, but that it will be even more in the rest of the world.

Two very strong realities and present in their own markets, came together, joined, to expand their borders and compete globally in a highly technological sector.” Salvatore Cincotti – CEO Technogenetics

 

richard

"In many ways, KHB and Technogenetics marriage symbolizes the global healthcare market.  When our group was founded in 1981, no one knew there would be an Italian company named Technogenetics established one year later, Certainly no one would imagine that 34 years later, we would be together, from 10,000 kilometers away.  But diseases tend to travel globally, science and medicine has no country boundaries.  What brings us together is our dedication to public health, our passion to science, our commitment to bring innovative products to the medical community worldwide. Technogenetics has a proud history, experienced scientific team and deep roots in Italy, while expanding its footprint in Europe. KHB has ambition to serve our customers globally.  Our alliance in Research and Development, Manufacturing and Commercialization will allow us to bring the best solution to patients and physicians and laboratories.  Today we see a newly decorated building, tomorrow we see innovative ideas translated into products, and somewhere a new patient will benefit. Let’s work together, let’s make Technogenetics a successful example how entrepreneurs from two countries could collaborate and have a bright future!” Richard Ding – CEO KHB Group

Once again, Italian know-how is underpinning ambitious global projects, while Chinese multinationals say they are ready to enter highly competitive and strategic sectors, such as in vitro diagnostics. The core of this partnership expects a first phase of integration of the know-how matured over the years, focusing on research centers in Italy, both Morra de Sanctis and Lodi, on the development of new products for the whole group. To the Italian research centers will be trusted with the ambitious development plans of the group and for researchers will be a unique opportunity to compete in a market that offers great growth prospects. KHB, in its trading strategy, sees this in the beginning of a process of expansion for new business opportunities in the European and North American markets.

Investments, Know-How and Quality will be the strength for targeting the global market!

© Technogenetics 2024. All rights reserved